CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Retained Earnings
Balance at beginning of period (in shares) at Dec. 31, 2022		107,698,000
Balance at beginning of period at Dec. 31, 2022	$ 1,568,558	$ 108	$ 1,293,565	$ (43,623)	$ 318,508
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	122,005				122,005
Other comprehensive income (loss)	4,886			4,886
Dividends declared	(52,529)				(52,529)
Net issuances of restricted stock (in shares)		831,000
Net issuances of restricted stock	0	$ 1	(1)
Stock-based compensation	15,434		15,434
Repurchases of common stock (in shares)		(766,000)
Repurchases of common stock	(59,873)	$ (1)			(59,872)
Balance at ending of period (in shares) at Mar. 31, 2023		107,763,000
Balance at end of period at Mar. 31, 2023	1,598,481	$ 108	1,308,998	(38,737)	328,112
Balance at beginning of period (in shares) at Dec. 31, 2022		107,698,000
Balance at beginning of period at Dec. 31, 2022	1,568,558	$ 108	1,293,565	(43,623)	318,508
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	228,297
Other comprehensive income (loss)	7,034
Balance at ending of period (in shares) at Jun. 30, 2023		107,132,000
Balance at end of period at Jun. 30, 2023	1,625,271	$ 107	1,324,451	(36,589)	337,302
Balance at beginning of period (in shares) at Mar. 31, 2023		107,763,000
Balance at beginning of period at Mar. 31, 2023	1,598,481	$ 108	1,308,998	(38,737)	328,112
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	106,292				106,292
Other comprehensive income (loss)	2,148			2,148
Dividends declared	(51,565)				(51,565)
Net issuances of restricted stock (in shares)		23,000
Stock-based compensation	15,453		15,453
Repurchases of common stock (in shares)		(654,000)
Repurchases of common stock	(45,538)	$ (1)			(45,537)
Balance at ending of period (in shares) at Jun. 30, 2023		107,132,000
Balance at end of period at Jun. 30, 2023	$ 1,625,271	$ 107	1,324,451	(36,589)	337,302
Balance at beginning of period (in shares) at Dec. 31, 2023	105,208,817	105,209,000
Balance at beginning of period at Dec. 31, 2023	$ 1,588,351	$ 105	1,354,703	(32,626)	266,169
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	63,701				63,701
Other comprehensive income (loss)	(11,379)			(11,379)
Dividends declared	(56,382)				(56,382)
Net issuances of restricted stock (in shares)		751,000
Net issuances of restricted stock	0	$ 1	(1)
Stock-based compensation	16,777		16,777
Repurchases of common stock (in shares)		(1,028,000)
Repurchases of common stock	(81,823)	$ (1)			(81,822)
Balance at ending of period (in shares) at Mar. 31, 2024		104,932,000
Balance at end of period at Mar. 31, 2024	$ 1,519,245	$ 105	1,371,479	(44,005)	191,666
Balance at beginning of period (in shares) at Dec. 31, 2023	105,208,817	105,209,000
Balance at beginning of period at Dec. 31, 2023	$ 1,588,351	$ 105	1,354,703	(32,626)	266,169
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	131,857
Other comprehensive income (loss)	$ (17,965)
Balance at ending of period (in shares) at Jun. 30, 2024	104,055,679	104,056,000
Balance at end of period at Jun. 30, 2024	$ 1,480,155	$ 104	1,387,110	(50,591)	143,532
Balance at beginning of period (in shares) at Mar. 31, 2024		104,932,000
Balance at beginning of period at Mar. 31, 2024	1,519,245	$ 105	1,371,479	(44,005)	191,666
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	68,156				68,156
Other comprehensive income (loss)	(6,586)			(6,586)
Dividends declared	(55,407)				(55,407)
Net issuances of restricted stock (in shares)		27,000
Stock-based compensation	15,631		15,631
Repurchases of common stock (in shares)		(903,000)
Repurchases of common stock	$ (60,884)	$ (1)			(60,883)
Balance at ending of period (in shares) at Jun. 30, 2024	104,055,679	104,056,000
Balance at end of period at Jun. 30, 2024	$ 1,480,155	$ 104	$ 1,387,110	$ (50,591)	$ 143,532